Genesis Energy LP (NYSE: GEL) has reported E.P.S. of $-0.58 for its fourth fiscal quarter (ending December 31) versus $-0.08 for the same period a year ago. For the latest four quarters through December 31, […]
For its first fiscal quarter (ending December 31), EMCORE Corp (NASDAQ: EMKR) has reported E.P.S. of $-0.60 compared to $-0.05 a year ago. This result fell short of the consensus estimate of $-0.18 by $-0.42. […]
Bruker Corporation (NASDAQ: BRKR) has reported E.P.S. of $0.09 for its fourth fiscal quarter (ending December 31) versus $1.41 for the same period a year ago — a decline of -94%. Relative to the consensus […]
For its fourth fiscal quarter (ending December 31), Bright Horizons Family Solutions (NYSE: BFAM) has reported a 400% increase in E.P.S. from $0.10 a year ago to $0.50 in the current quarter. However, this performance […]
For its first fiscal quarter (ending January 31), Applied Materials Inc (NASDAQ: AMAT) has reported a -40% decline in E.P.S. from $2.43 a year ago to $1.46 in the current quarter. This result fell short […]
American Electric Power Co Inc (NASDAQ: AEP) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.25 versus $0.64 for the same period a year ago — an increase of 95%. Relative […]
Wynn Resorts Ltd (NASDAQ: WYNN) has reported earnings for its fourth fiscal quarter (ending December 31) of $2.56 versus $6.53 for the same period a year ago — a decline of -61%. However, this performance […]
For its fourth fiscal quarter (ending December 31), Wendy’s Co (NASDAQ: WEN) has reported a 0% change in E.P.S. from $0.23 a year ago to $0.23 in the current quarter. Relative to the consensus estimate […]
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has reported E.P.S. of $-0.08 for its fourth fiscal quarter (ending December 31) versus $-0.04 for the same period a year ago. E.P.S. were $-0.33 for the latest four quarters […]
On 2/13/25, Trinet Group Inc (NYSE: TNET) stock suffered a major decline of -14.8%, closing at $78.49. Moreover, trading volume in this decline was exceptionally high at 383% of normal. Relative to the market the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research